• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列环素对血小板因子3活性的抑制作用。

Inhibition of platelet factor 3 availability by prostacyclin.

作者信息

Hársfalvi J, Muszbek L, Stadler I, Fésüs L

出版信息

Prostaglandins. 1980 Nov;20(5):935-45. doi: 10.1016/0090-6980(80)90143-4.

DOI:10.1016/0090-6980(80)90143-4
PMID:7008092
Abstract

Preincubation of human platelet rich plasma with PGI2 in a concentration preventing collagen induced platelet aggregation abolished also platelet factor 3 availability brought about by collagen. Following PGI2 pretreatment no second wave aggregation could be elicited by ristocetin. However, primary aggregation as well as platelet factor 3 activity were only partially inhibited in this case and the inhibitory action of PGI2 was not increased by raising its concentration. Similarly, marked but not complete inhibition of platelet factor 3 availability was obtained when kaolin was used as activating agent.

摘要

将富含人血小板的血浆与前列环素(PGI2)进行预温育,当PGI2浓度能防止胶原诱导的血小板聚集时,由胶原引起的血小板第3因子有效性也会消失。PGI2预处理后,瑞斯托菌素不能引发第二波聚集。然而,在这种情况下,初级聚集以及血小板第3因子活性仅被部分抑制,并且提高PGI2浓度并不能增强其抑制作用。同样,当用高岭土作为激活剂时,血小板第3因子有效性会受到显著但不完全的抑制。

相似文献

1
Inhibition of platelet factor 3 availability by prostacyclin.前列环素对血小板因子3活性的抑制作用。
Prostaglandins. 1980 Nov;20(5):935-45. doi: 10.1016/0090-6980(80)90143-4.
2
Platelets, von Willebrand factor, and prostaglandin I2.血小板、血管性血友病因子和前列腺素I2。
Am J Physiol. 1981 Jul;241(1):H54-9. doi: 10.1152/ajpheart.1981.241.1.H54.
3
Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.人类血小板活化的调节——环氧合酶和环磷酸腺苷依赖性途径的分析
Biochem Pharmacol. 1984 Oct 1;33(19):3025-35. doi: 10.1016/0006-2952(84)90604-x.
4
Effect of prostacyclin derivatives on platelet factor 3 availability.前列环素衍生物对血小板第3因子有效性的影响。
Thromb Res. 1987 Jul 1;47(1):117-21. doi: 10.1016/0049-3848(87)90248-9.
5
6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
Eur J Pharmacol. 1979 Dec 7;60(2-3):245-8. doi: 10.1016/0014-2999(79)90225-5.
6
Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.前列环素对血小板活化因子诱导的兔血小板聚集的影响。
Prostaglandins. 1980 Nov;20(5):781-91. doi: 10.1016/0090-6980(80)90133-1.
7
Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.前列环素(PGI2)、前列腺素E1和D2对不同物种血小板聚集作用的比较。
Prostaglandins. 1978 Sep;16(3):373-88. doi: 10.1016/0090-6980(78)90216-2.
8
The influence of age, sex, and the use of oral contraceptives on the inhibitory effects of endothelial cells and PGI2 (prostacyclin) on platelet function.年龄、性别以及口服避孕药的使用对内皮细胞和前列环素(PGI2)抑制血小板功能的影响。
Scand J Haematol. 1978 Sep;21(3):177-87. doi: 10.1111/j.1600-0609.1978.tb00352.x.
9
Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.保泰松、萘普生和氟尼辛葡甲胺对马血小板聚集及体外血小板第3因子有效性的比较作用
Can J Comp Med. 1983 Apr;47(2):172-9.
10
Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.前列环素(PGI2)可抑制人类血小板中由二磷酸腺苷(ADP)和花生四烯酸诱导的形态变化及促凝血活性的发展。
Prostaglandins. 1980 Dec;20(6):1103-16. doi: 10.1016/0090-6980(80)90063-5.